August 6, 2019 — IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution with The University of Kansas Health System. The contract includes a plan for a possible extension with a second ProteusOne unit in the future. The proton therapy center will be built at the Main Campus of The University of Kansas Health System in Kansas City, Kansas. Construction is anticipated to begin later this year.
The contract includes a long-term operation and maintenance agreement and the typical end-user price for a Proteus One solution, with a maintenance contract between EUR 35 and 40 million. IBA will begin to recognize revenue for the contract in the 2019 financial year.
Bob Page, president and chief executive officer of The University of Kansas Health System commented, “We are excited to partner with IBA, the world’s leading proton therapy system provider, to bring proton therapy to Kansas City and the region. IBA’s Proteus One represents one of the most advanced solutions to delivering proton therapy. With the first system in place, and the ability to add a second system in the future, patients will be able to stay closer to home to receive the most advanced cancer care available.”
Proteus One is the compact intensity modulated proton therapy (IMPT) solution from IBA, benefiting from the latest technologies. The system is smaller, more affordable, easier to install and to operate.
For more information: www.iba-worldwide.com